Generate Biomedicines, Inc.

NASDAQ:GENB

Asset Management

Financial Services
$10.38 +0.91%

+$0.13 today

Market cap
$1.34B
Beta
0.19
P/E (TTM)
-3.5
EPS (TTM)
-$4.06
52W Low $11.00High $16.75

Volume 1.05M

Average 0.55M

GENB Inventory

Cash effect of the change in inventory; building inventory consumes cash.

Generate Biomedicines, Inc.NASDAQ: GENB

Inventory · Q1 FY2026 · quarter ended Mar 2026

Inventory of $0 in Q1 FY2026

Q1 FY2026 inventory was $0.

Context

  • Inventory amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Inventory vs competitors

How GENB compares with its peers on the latest reported figures

  • GENB's FY2025 inventory of $0 is the largest of the 5 companies compared; the peer median is $0.
  • Inventory amounts to 0.0% of revenue for GENB, versus a peer median of 0.0%.
GENB Competitors Peer median
Inventory for GENB and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GENBGenerate Biomedicines, Inc.FY2025$0 ——0.0%
ABCLAbCellera Biologics Inc.LTM Sep 2026$0 ——0.0%
ABSIAbsci CorporationLTM Mar 2026$0 ——0.0%
INBXInhibrx Biosciences, Inc.LTM Mar 2026$0 ——0.0%
STROSutro Biopharma, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding GENB) $0——0.0%

Competitors are the stored peer set for GENB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD

Generate Biomedicines, Inc.

NASDAQ:GENB

Intrinsic Alpha fair value

Locked

Current Price

$10.38

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.